http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022520132-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022520132-A |
| titleOfInvention | Synthesis of bioactive Ganoderma lucidum compounds and anti-cancer derivatives; ergosterol peroxide probe for cell localization |
| abstract | Bioactive compounds of Ganoderma lucidum extract (GLE) involved in anticancer activity have been elucidated using NMR, X-ray crystallography and analog derivatization, and anticancer activity studies. The structures of the seven most abundant GLE compounds are disclosed. Their selective efficacy against triple-negative (TNBC) and inflammatory breast cancer (IBC), as well as other human cancer cell types (solid malignancies and hematological malignancies) has been demonstrated and their as anti-cancer agents. Confirmed potential. |
| priorityDate | 2019-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 392.